Inhibition of RNA polymerase I transcription activates targeted DNA damage response and enhances the efficacy of PARP inhibitors in high-grade serous ovarian cancer.
| Authors | Sanij, Elaine; Hannan, Katherine; Xuan, Jiachen; Yan, Shunfei; Ahern, Jessica A.; Trigos, Anna S.; Brajanovski, Natalie; Son, Jinbae; Chan, Keefe T.; Kondrashova, Olga; Lieschke, Elizabeth; Wakefield, Matthew J.; Ellis, Sarah; Cullinane, Carleen; Poortinga, Gretchen; Khanna, Kum Kum; Mileshkin, Linda; McArthur, Grant A.; Soong, John; Berns, Els M.; Hannan, Ross D.; Scott, Clare L.; Sheppard, Karen E.; Pearson, Richard B. |
|---|---|
| Journal | CLINICAL CANCER RESEARCH |
| Pages | 74-75 |
| Volume | 26 |
| Date | 1/07/2020 |
| Grant ID | |
| Funding Body |